As used in this article, the term:
(1) “Alzheimer’s disease” or “Alzheimer’s related dementia” means a progressive, degenerative disease or condition that attacks the brain and results in impaired memory, thinking, and behavior.
(2) “Care,” “treatment,” and “therapeutic activities” shall not include the sole activity of marketing, selling, manufacturing, or dispensing medication which is approved by the United States Food and Drug Administration and prescribed by a person licensed to practice medicine in accordance with Chapter 34 of Title 43 and informational or support services related to the use of such medication.
(3) “Department” means the Department of Community Health.